Details for New Drug Application (NDA): 207219
✉ Email this page to a colleague
The generic ingredient in DULOXETINE HYDROCHLORIDE is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.
Summary for 207219
Tradename: | DULOXETINE HYDROCHLORIDE |
Applicant: | Yaopharma Co Ltd |
Ingredient: | duloxetine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 207219
Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 207219
Suppliers and Packaging for NDA: 207219
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 207219 | ANDA | Yaopharma Co., Ltd. | 50771-201 | 50771-201-01 | 60 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (50771-201-01) |
DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 207219 | ANDA | Yaopharma Co., Ltd. | 50771-202 | 50771-202-01 | 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (50771-202-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 20MG BASE | ||||
Approval Date: | Aug 16, 2019 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 30MG BASE | ||||
Approval Date: | Aug 16, 2019 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 60MG BASE | ||||
Approval Date: | Aug 16, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription